Difference between revisions of "Team:Harvard BioDesign/Platform"

Line 142: Line 142:
 
                 reliably determine how our system is functioning and selected relevant positive and negative
 
                 reliably determine how our system is functioning and selected relevant positive and negative
 
                 control strains to differentiate real from imaginary results. Using the tools of synthetic biology,
 
                 control strains to differentiate real from imaginary results. Using the tools of synthetic biology,
                 we created <a href="https://2015.igem.org/Team:Harvard_BioDesign/Parts">BioBricks</a> which can be  
+
                 we created <a href="https://2015.igem.org/Team:Harvard_BioDesign/Parts">BioBricks</a> which can be
 
                 integrated into complex biological circuits where specific interaction with the physical environment is a must. Furthermore, we created a workflow
 
                 integrated into complex biological circuits where specific interaction with the physical environment is a must. Furthermore, we created a workflow
 
                 that can be used to integrate any desired binding specificity into our system, and modified the native
 
                 that can be used to integrate any desired binding specificity into our system, and modified the native
Line 158: Line 158:
 
           <section class="two">
 
           <section class="two">
 
             <div class="container">
 
             <div class="container">
 +
              <header><h2>Strains and Assays</h2></header>
 +
              <p>
 +
                Before we could begin engineering the Fim system (link to Ben's description of the operon) we needed to establish a positive and negative baseline for the experiments we'd use to categorize our constructs. We selected two strains from the Yale's Keio collection (link) of nonessential gene knockouts which are each missing one of the recombinases that comprises the fim “switch” (link to Ben's background). We hypothesized based on the literature that a knockout for the fimB recombinase (Keio strain name JW4276) will not produce pili because fimE is biased to switch in the direction of “on” to “off” (switchAndInteractionfimEandB). When fimB is absent, fimE would switch the operon “off”. Contrarily, a knockout for fim E (Keio name- JW4276) will overproduce pili because fimB switches both “on” to “off” and “off” to “on”, so the operon will be “on” more than it would if both were present.
 +
              </p>
 
               <img src="https://static.igem.org/mediawiki/2015/c/c2/Harvard_Colon_Cancer_Tumor.png" alt="Colon Tumor" style="width:472px;height:337px;margin-top:-10px;margin-bottom:35px;border:1px solid darkgrey;"/>
 
               <img src="https://static.igem.org/mediawiki/2015/c/c2/Harvard_Colon_Cancer_Tumor.png" alt="Colon Tumor" style="width:472px;height:337px;margin-top:-10px;margin-bottom:35px;border:1px solid darkgrey;"/>
              <header><h2>Looking <i>Closely</i> at the Problem</h2></header>
 
 
               <p>
 
               <p>
                 Explanation of how we thought through potential solutions in the context of the microbiome.
+
                 To confirm this hypothesis we used an agglutination assay (protocol here link to protocol) from the literature which is standard for measuring the expression of Type 1 Pili (Klemm, Schembri, Stentebjerg-Olesen, Hasman, Hasty 1998).
                 Statistics and links to external sites about the prevalence of bacteria in the gut. Motivations
+
              </p>
                 from the perspective of synthetic biology to address the problem of colon cancer with the power
+
              <img src="https://static.igem.org/mediawiki/2015/c/c2/Harvard_Colon_Cancer_Tumor.png" alt="Colon Tumor" style="width:472px;height:337px;margin-top:-10px;margin-bottom:35px;border:1px solid darkgrey;"/>
                 of synthetic biology. However, we’re unable to use the power of synthetic biology.
+
              <p>
 +
                This protocol tests whether a culture of E. coli cells can agglutinate--clump together--a substrate which contains the binding partner (link to background) of fimH, mannose sugar. We chose to try to clump together S. cervisiae (baker's yeast) because it expresses mannose on its cell surface, is easy to grow in lab, and has been used in this assay before (Eshdat, Speth, Jann 1981).
 +
<br>
 +
We found that the fimE KO we hypothesized would overproduce type 1 pili indeed agglutinated the yeast, as indicated by a white clump at the bottom of the tube. The fim B KO samples showed no sign of clumping and were completely opaque:
 +
              </p>
 +
              <img src="https://static.igem.org/mediawiki/2015/d/dc/Harvard2015FirstAgglutination.png" alt="Colon Tumor" style="width:472px;height:337px;margin-top:-10px;margin-bottom:35px;border:1px solid darkgrey;"/>
 +
              <p>
 +
                 To confirm these results, we examined equal volumes of OD standardized (protocol link) agglutinated samples from either strain under light microscopy. Slides were prepared according to the slide preparation protocol (link) and to visualize the bacteria and yeast, we stained the slides according to the Gram Stain protocol (link).
 +
                <br>
 +
                These photos are representative of the morphology of each sample. The large purple circular cells are S. cerevisiae and the small pink cocci are E. coli:
 +
              </p>
 +
              <img src="https://static.igem.org/mediawiki/2015/b/be/Harvard2015FimBKO.png" alt="Colon Tumor" style="width:472px;height:337px;margin-top:-10px;margin-bottom:35px;border:1px solid darkgrey;"/>
 +
              <img src="https://static.igem.org/mediawiki/2015/b/be/Harvard2015FimEKO.png" alt="Colon Tumor" style="width:472px;height:337px;margin-top:-10px;margin-bottom:35px;border:1px solid darkgrey;"/>
 +
              <p>
 +
                At this point we were confident in the agglutination assay’s ability to detect the presence of pili via mannose-mediated adhesion. However, we hypothesized that our future modifications of the fimH adhesin might lead to weakened mannose binding strength even while the pili were still properly assembling.  We required a diagnostic assay that would detect whether type 1 Pili were present on the cell surface even when fimH no longer bound to mannose. So we conducted extensive literature review and developed the (Pili Purification Protocol link) with the aim of a rapid test to provide a “yes” or “no” answer to this question.
 +
              </p>
 +
              <p>
 +
                 We first tested our assay on our control strains, growing both the overproducer and null strain overnight in LB liquid culture, then OD standardizing (protocol) to ensure our results were not dependent on variable cell growth. Then a volume of each sample was spun down at low speed (so as not to lyse the cells), washed once in DPBS to remove secreted proteins, and resuspended in a smaller volume of DPBS to concentrate the signal in later steps. These samples were then heat treated for 20 minutes at 60°C to shear-off the pili from the cell surface and spun down again at low-speed so the cells would pellet but the sheared pili would remain in solution. This pili-containing supernatant was then denatured using formic acid, boiled in 1x Lamelli’s buffer and run according to the SDS-PAGE protocol (link). The resulting gels were stained according to the R-250 Coomassie protocol (link) and compared at the molecular weight of Type 1 Pili’s structural subunit protein, fimA, which is most abundant. We hypothesized that the pili overproducing fimE would show a strong band at this weight compared to the null fimB strain. The resulting gel is below:
 +
              </p>
 +
              <img src="https://static.igem.org/mediawiki/2015/c/cc/Harvard2015Westernness.png" alt="Colon Tumor" style="width:472px;height:337px;margin-top:-10px;margin-bottom:35px;border:1px solid darkgrey;"/>
 +
              <p>
 +
                Caption: “A band is present at the expected weight in the purified pili of the fimE overproducer. We tried testing the purification with and without formic acid acid denaturation. The fimA band is stronger in the formic acid treated sample which indicates that the pili are insoluble and need to be broken up for detection”
 +
              </p>
 +
              <p>
 +
                 Indeed, we see a dark band at 16.5 kD, the molecular weight of fimA, but only for the fimE overproducing strain, not for our negative control. This shows our pili purification method gives a clear signal to detect pili production, and can be used to characterize our modified Type 1 Pili and by future teams using our system. With functional assays and positive and negative controls, we felt confident that we had the tools necessary to begin engineering control over pili expression.
 
               </p>
 
               </p>
 
             </div>
 
             </div>
Line 171: Line 198:
 
           <section class="three">
 
           <section class="three">
 
             <div class="container">
 
             <div class="container">
              <img src="https://static.igem.org/mediawiki/2015/c/c2/Harvard_Colon_Cancer_Tumor.png" alt="Colon Tumor" style="width:472px;height:337px;margin-top:-10px;margin-bottom:35px;border:1px solid darkgrey;"/>
+
               <header><h2>Construct Design</h2></header>
               <header><h2>Inspiration from Nature  - Type 1 Pili</h2></header>
+
 
               <p>
 
               <p>
 
                 Enter Type 1 fimbriae. Start by saying that interaction with the physical environment is a
 
                 Enter Type 1 fimbriae. Start by saying that interaction with the physical environment is a

Revision as of 06:44, 18 September 2015


Prologue by HTML5 UP

Project Logo

BactoGrip: Our Platform

This summer we dedicated ourselves to building a modular, durable, biomimetic platform for synthetic biologists who need to control bacterial adhesion. We developed a set of assays to reliably determine how our system is functioning and selected relevant positive and negative control strains to differentiate real from imaginary results. Using the tools of synthetic biology, we created BioBricks which can be integrated into complex biological circuits where specific interaction with the physical environment is a must. Furthermore, we created a workflow that can be used to integrate any desired binding specificity into our system, and modified the native protein so that it is easy to work with and measure under diverse experimental conditions. We call our system BactoGrip, and we hope you will find it as gripping as we do.

Strains and Assays

Before we could begin engineering the Fim system (link to Ben's description of the operon) we needed to establish a positive and negative baseline for the experiments we'd use to categorize our constructs. We selected two strains from the Yale's Keio collection (link) of nonessential gene knockouts which are each missing one of the recombinases that comprises the fim “switch” (link to Ben's background). We hypothesized based on the literature that a knockout for the fimB recombinase (Keio strain name JW4276) will not produce pili because fimE is biased to switch in the direction of “on” to “off” (switchAndInteractionfimEandB). When fimB is absent, fimE would switch the operon “off”. Contrarily, a knockout for fim E (Keio name- JW4276) will overproduce pili because fimB switches both “on” to “off” and “off” to “on”, so the operon will be “on” more than it would if both were present.

Colon Tumor

To confirm this hypothesis we used an agglutination assay (protocol here link to protocol) from the literature which is standard for measuring the expression of Type 1 Pili (Klemm, Schembri, Stentebjerg-Olesen, Hasman, Hasty 1998).

Colon Tumor

This protocol tests whether a culture of E. coli cells can agglutinate--clump together--a substrate which contains the binding partner (link to background) of fimH, mannose sugar. We chose to try to clump together S. cervisiae (baker's yeast) because it expresses mannose on its cell surface, is easy to grow in lab, and has been used in this assay before (Eshdat, Speth, Jann 1981).
We found that the fimE KO we hypothesized would overproduce type 1 pili indeed agglutinated the yeast, as indicated by a white clump at the bottom of the tube. The fim B KO samples showed no sign of clumping and were completely opaque:

Colon Tumor

To confirm these results, we examined equal volumes of OD standardized (protocol link) agglutinated samples from either strain under light microscopy. Slides were prepared according to the slide preparation protocol (link) and to visualize the bacteria and yeast, we stained the slides according to the Gram Stain protocol (link).
These photos are representative of the morphology of each sample. The large purple circular cells are S. cerevisiae and the small pink cocci are E. coli:

Colon Tumor Colon Tumor

At this point we were confident in the agglutination assay’s ability to detect the presence of pili via mannose-mediated adhesion. However, we hypothesized that our future modifications of the fimH adhesin might lead to weakened mannose binding strength even while the pili were still properly assembling. We required a diagnostic assay that would detect whether type 1 Pili were present on the cell surface even when fimH no longer bound to mannose. So we conducted extensive literature review and developed the (Pili Purification Protocol link) with the aim of a rapid test to provide a “yes” or “no” answer to this question.

We first tested our assay on our control strains, growing both the overproducer and null strain overnight in LB liquid culture, then OD standardizing (protocol) to ensure our results were not dependent on variable cell growth. Then a volume of each sample was spun down at low speed (so as not to lyse the cells), washed once in DPBS to remove secreted proteins, and resuspended in a smaller volume of DPBS to concentrate the signal in later steps. These samples were then heat treated for 20 minutes at 60°C to shear-off the pili from the cell surface and spun down again at low-speed so the cells would pellet but the sheared pili would remain in solution. This pili-containing supernatant was then denatured using formic acid, boiled in 1x Lamelli’s buffer and run according to the SDS-PAGE protocol (link). The resulting gels were stained according to the R-250 Coomassie protocol (link) and compared at the molecular weight of Type 1 Pili’s structural subunit protein, fimA, which is most abundant. We hypothesized that the pili overproducing fimE would show a strong band at this weight compared to the null fimB strain. The resulting gel is below:

Colon Tumor

Caption: “A band is present at the expected weight in the purified pili of the fimE overproducer. We tried testing the purification with and without formic acid acid denaturation. The fimA band is stronger in the formic acid treated sample which indicates that the pili are insoluble and need to be broken up for detection”

Indeed, we see a dark band at 16.5 kD, the molecular weight of fimA, but only for the fimE overproducing strain, not for our negative control. This shows our pili purification method gives a clear signal to detect pili production, and can be used to characterize our modified Type 1 Pili and by future teams using our system. With functional assays and positive and negative controls, we felt confident that we had the tools necessary to begin engineering control over pili expression.

Construct Design

Enter Type 1 fimbriae. Start by saying that interaction with the physical environment is a huge problem in nature and has been worked on for billions of years. Make clear that we’re inspired by nature and that we’re mimicking nature’s design. In biological systems Type 1 Pili typically manifest as organelles on the surface of pathogenic E. coli which are responsible for urinary tract infections in humans. The pili are translated from the “Fim” system of genes in the E. coli genome. Formation of individual pili consists of a “chaperone-usher” pathway whereupon a fimD “chaperone” protein binds to a subunit of the pili and “ushers” it through a membrane pore to bind it to the elongating pilus. Repeating fimA subunits form the base of a helical rod roughly 7 nm in length, which are attached to two adapter proteins (FimF and FimG) and finally the FimH adhesin at the end of the pilus. The role which the pili play in these infections follows from its structure. FimH contains a mannose-binding domain which binds to mannose-containing receptors in host cells in the urinary tract epithelial tissue, activating a phagocytic process within the cells, leading to bacterial invasion and replication in the host cells (Wolf et al., 2002).


In the Fim genetic circuit, the FimE and FimB recombinases play an especially significant role in regulating expression of the Fim system and the resulting pili production. Containing an invertible 314-bp element called the “Fim switch,” the system is only able to be transcribed by the promoter when this switch is in the “on” orientation. FimE and FimB are located upstream of the rest of the Fim operon subunits.

Colon Tumor

Controlling Bacterial Adhesion

(Our Approach)

Research Process

A Toolkit

Textual elaboration of the graphic. We won’t go into detail on the construct design here or the fusion sites on fimH; speak generally to the spirit and inspiration of our process, emphasize graphically the modularity and reusability of the system.


The problem of controlled bacterial adhesion spans biology and we mean to solve it! Our approach and the biobricks we have submitted to the registry will be a resource for future iGEM teams to control adhesion in a myriad of contexts.

Gripping Applications